Extracorporeal photopheresis: past, present, and future
R Knobler, ML Barr, DR Couriel, JLM Ferrara… - Journal of the American …, 2009 - Elsevier
… Extracorporeal photopheresis (ECP) was initially developed for use in cutaneous T-cell …
Here, also, long-term treatment (years) seems to lead to continuous improvement of this …
Here, also, long-term treatment (years) seems to lead to continuous improvement of this …
[HTML][HTML] Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis …
HT Greinix, K van Besien, AH Elmaagacli… - Biology of Blood and …, 2011 - Elsevier
… In conclusion, progressive improvement in cutaneous and extracutaneous cGVHD was
observed after a 24-week course of ECP in patients who previously had no clinical improvement …
observed after a 24-week course of ECP in patients who previously had no clinical improvement …
Guidelines on the use of extracorporeal photopheresis
R Knobler, G Berlin, P Calzavara‐Pinton… - Journal of the …, 2014 - Wiley Online Library
… patients with steroid-refractory cGVHD, progressive improvement in the TSS during weeks 16
… Significantly improved survival rates and improvements in quality of life in ECP responders …
… Significantly improved survival rates and improvements in quality of life in ECP responders …
Extracorporeal photopheresis as a therapy for autoimmune diseases
Z Kuzmina, D Stroncek… - Journal of clinical …, 2015 - Wiley Online Library
… important that outcome measures record best clinical improvement but also disease
stabilization, prevention from further disability or death from chronic progressive AID are important. …
stabilization, prevention from further disability or death from chronic progressive AID are important. …
Extracorporeal photopheresis: technique, established and novel indications
MB Marques, J Adamski - Journal of Clinical Apheresis, 2014 - Wiley Online Library
Extracorporeal photopheresis (ECP) has had a major impact in the treatment of various
conditions in the past 25 years. Although it was initially developed for the treatment of patients …
conditions in the past 25 years. Although it was initially developed for the treatment of patients …
Extracorporeal photopheresis: clinical use so far
KW Sanford, RA Balogun - Journal of Clinical Apheresis, 2012 - Wiley Online Library
… In this study, 14 patients improved with seven attaining remission by 12 weeks. Of five
patients who had persistently open fistulas, three patients experienced fistula closure after ECP …
patients who had persistently open fistulas, three patients experienced fistula closure after ECP …
Extracorporeal photopheresis—an overview
A Cho, C Jantschitsch, R Knobler - Frontiers in medicine, 2018 - frontiersin.org
… studies with varying outcome, ranging from no improvement against no treatment, improvement
over no treatment but no improvement against sham to a superiority of ECP against D-…
over no treatment but no improvement against sham to a superiority of ECP against D-…
Clinical results of extracorporeal photopheresis
N Worel, G Leitner - Transfusion Medicine and Hemotherapy, 2012 - karger.com
… Extracorporeal photochemotherapy (ECP) was introduced in … clinical response and faster
improvement in patients receiving … treatment leads to continuous improvement in SSc patients. …
improvement in patients receiving … treatment leads to continuous improvement in SSc patients. …
Role of extracorporeal photopheresis in the management of acute and chronic graft versus disease: current status
M Lozano, P Charry, M de Pablo-Miró… - Bone Marrow …, 2024 - nature.com
… Extracorporeal photopheresis (ECP) is a therapy that combines the collection of … GvHD, the
steroid-sparing effect, and the improved overall survival of treated patients, made ECP one of …
steroid-sparing effect, and the improved overall survival of treated patients, made ECP one of …
European dermatology forum–updated guidelines on the use of extracorporeal photopheresis 2020–part 1
R Knobler, P Arenberger, A Arun… - Journal of the …, 2020 - Wiley Online Library
… Other dedicated continuous or … improved functionality, reduced symptoms and improved
well-being. Despite not reaching a partial response (better by 50%) in skin diseases, continuous …
well-being. Despite not reaching a partial response (better by 50%) in skin diseases, continuous …
相关搜索
- cell lymphoma extracorporeal photopheresis
- updated guidelines extracorporeal photopheresis
- autoimmune diseases extracorporeal photopheresis
- extracorporeal photopheresis ecp in the treatment
- influence of extracorporeal photopheresis
- extracorporeal photopheresis therapy
- 24 week course progressive improvement
- extensive chronic graft extracorporeal photochemotherapy
- extracorporeal photopheresis in pediatric patients
- significant disease response extracorporeal photopheresis
- multicenter prospective phase extracorporeal photopheresis
- analysis of response extracorporeal photopheresis
- guidelines on the use extracorporeal photopheresis
- immunological diseases extracorporeal photopheresis
- review of technical aspects extracorporeal photopheresis
- scientific opportunities extracorporeal photopheresis